Philips Launches IntraSight Plus to Slash Cathlab Operating Times by Nearly Half
Philips launches FDA-cleared IntraSight Plus interventional platform, offering up to 47% cathlab operation time savings with integrated diagnostic and treatment planning capabilities.
PHGFDA clearanceminimally invasive procedures